News
Eli Lilly looks attractively valued, with P/E ratios well below historical averages and robust momentum in Zepbound and ...
GLP-1 receptor agonists such as the popular weight loss/diabetes therapies Mounjaro, developed by Eli Lilly (NYSE:LLY), and ...
18hon MSN
Eli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried?
Eli Lilly › Eli Lilly (NYSE: LLY) has been a terrific stock to own over the past 15 years; it has consistently outperformed ...
Criminals were caught trying to import the likes of Wegovy and Mounjaro in 'large-scale' smuggling operations.
CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication.
Eli Lilly and Company (NYSE:LLY) is one of the Reddit Stocks with the Highest Upside Potential. On August 7, the company ...
BRITAIN has gone fat jab crazy — with sales of Wegovy soaring by more than 2,000 per cent in the past month. Dieters are ...
Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...
4d
Zacks.com on MSNLilly Stock Down 5% This Month: Should You Buy the Dip?
Eli Lilly stock is down 5% this month despite strong Q2 results and raised guidance, as data from a study on the obesity pill ...
Pharmaceutical giant Eli Lilly said last week that it will raise the U.K. list price of its weight-loss treatment Mounjaro by ...
The company said it was reviewing Mounjaro pricing with other governments and expected to make similar adjustments in certain ...
A MAJOR high street pharmacy has stopped selling Mounjaro amid a nationwide shortage of the popular fat jab. It comes just days after The Sun revealed the price of the ‘King Kong’ injection would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results